Skip to main content

Advertisement

SpringerLink
Log in

Nonalcoholic fatty liver disease in India – a lot done, yet more required!

  • Review Article
  • Published:
Indian Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Nonalcoholic fatty liver disease (NAFLD) is emerging as an important cause of liver disease in India. Epidemiological studies suggest prevalence of NAFLD in around 9% to 32% of general population in India with higher prevalence in those with overweight or obesity and those with diabetes or prediabetes. Clinicopathological studies show that NAFLD is an important cause of unexplained rise in hepatic transaminases, cryptogenic cirrhosis and cryptogenic hepatocellular carcinoma in Indian patients. There is high prevalence of insulin resistance and nearly half of Indian patients with NAFLD have evidence of full-blown metabolic syndrome. Though oxidative stress is involved in the pathogenesis of NAFLD/nonalcoholic steatohepatitis, serum or liver iron and HFE gene mutations appear not to play a role in the pathogenesis of NAFLD in Indian patients. Imaging modalities are not useful in differentiating simple steatosis from NASH and liver biopsy may be useful in those with risk factors for significant liver disease. Pilot studies on treatment strategies have shown that weight reduction and exercise, ursodeoxycholic acid, metformin, vitamin E and pentoxyfylline are effective in normalizing transaminases and or in improving hepatic steatosis and inflammation in Indian patients with NAFLD. Randomized controlled treatment trials involving large number of patients with histological end point are required to assess the efficacy of different modalities. In conclusion, a lot has been done, yet more is required to understand various aspects of NAFLD in India.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Falck-Ytter Y, Younossi ZM, Marchesini G, Mc Cullough AJ. Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis. 2001;21:17–26.

    Article  CAS  PubMed  Google Scholar 

  2. Ludwig J, Viggiano T, McGill D, Ott B. Nonalcoholic steatohepatitis. Mayo Clinic experience with a hitherto unnamed disease. Mayo Clin Proc. 1980;55:434–8.

    CAS  PubMed  Google Scholar 

  3. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346:1221–31.

    Article  CAS  PubMed  Google Scholar 

  4. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology. 2002;123:1705–25.

    Google Scholar 

  5. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology. 2003;37:1202–19.

    Article  PubMed  Google Scholar 

  6. Misra A, Vikram NK. Insulin resistance syndrome (metabolic syndrome) and obesity in Asian Indians: evidence and implications. Nutrition. 2004;20:482–91.

    Article  CAS  PubMed  Google Scholar 

  7. Misra A, Luthra K, Vikram NK. Dyslipidemia in Asian Indians: determinants and significance. J Assoc Physicians India. 2004;52:137–42.

    CAS  PubMed  Google Scholar 

  8. Ramachandran A, Snehalatha C, Satyavani K, Vijay V. Impaired fasting glucose and impaired glucose tolerance test in urban population in India. Diabet Med. 2003;20:220–4.

    Article  CAS  PubMed  Google Scholar 

  9. Duseja A, Chawla Y. Nonalcoholic fatty liver disease in India: how much? How soon? Trop Gastroenterol. 2005;26:1–3.

    PubMed  Google Scholar 

  10. Singh SP, Nayak S, Swain M, et al. Prevalence of nonalcoholic fatty liver disease in coastal eastern India: a preliminary ultrasonographic survey. Indian J Gastroenterol. 2004;25:76–9.

    Google Scholar 

  11. Amarapurkar D, Kamani P, Patel N, et al. Prevalence of non-alcoholic fatty liver disease: population based study. Ann Hepatol. 2007;6:161–3.

    PubMed  Google Scholar 

  12. Mohan V, Farooq S, Deepa M, Ravikumar R, Pitchumoni CS. Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome. Diabetes Res Clin Pract. 2009;84:84–91.

    Article  CAS  PubMed  Google Scholar 

  13. Das K, Das K, Mukherjee PS, et al. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease. Hepatology. 2010;51:1593–602.

    Article  CAS  PubMed  Google Scholar 

  14. Duseja A, Bhansali A, Bhadada S, Jain P, Dhiman RK, Chawla Y. Nonalcoholic fatty liver disease in patients with recent onset type 2 diabetes mellitus (abstract). J Gastroenterol Hepatol. 2004;19 Suppl:A402.

    Google Scholar 

  15. Gupte P, Amarapurkar D, Agal S, et al. Non alcoholic steatohepatitis in type 2 diabetes mellitus. J Gastroenterol Hepatol. 2004;19:854–8.

    Article  PubMed  Google Scholar 

  16. Banerjee S, Ghosh US, Dutta S. Clinicopathological profile of hepatic involvement in type-2 diabetes mellitus and its significance. J Assoc Physicians India. 2008;56:593–9.

    CAS  PubMed  Google Scholar 

  17. Madan K, Batra Y, Panda SK, et al. Role of polymerase chain reaction and liver biopsy in the evaluation of patients with asymptomatic transaminitis: Implications in diagnostic approach. J Gastroenterol Hepatol. 2004;19:1291–9.

    Google Scholar 

  18. Dhiman RK, Duseja A. Nonalcoholic Fatty Liver Disease. In. J Assoc Physicians India. Medicine Update. Eds. Gupta SB. 2005;15:469–75.

  19. Amarapurkar DN, Patel ND. Clinical spectrum and natural history of non-alcoholic steatohepatitis with normal alanine aminotransferases values. Trop Gastroenterol. 2004;25:130–4.

    PubMed  Google Scholar 

  20. Amrapurkar D, Das HS. Chronic liver disease in diabetes mellitus. Trop Gastroenterol. 2002;23:3–5.

    Google Scholar 

  21. Duseja A, Nanda M, Das A, Das R, Bhansali A, Chawla Y. Prevalence of obesity, diabetes mellitus and hyperlipidemia in patients with cryptogenic liver cirrhosis. Trop Gastroenterol. 2004;25:15–7.

    PubMed  Google Scholar 

  22. Nayak NC, Vasdev N, Saigal S, Soin AS. End-stage nonalcoholic fatty liver disease: evaluation of pathomorphologic features and relationship to cryptogenic cirrhosis from study of explant livers in a living donor liver transplant program. Hum Pathol. 2010;41:425–30.

    Article  PubMed  Google Scholar 

  23. Duseja A, Sharma BK, Kumar A, et al. Nonalcoholic fatty liver in a developing country is responsible for significant liver disease. Hepatology. 2010;52:2248–9.

    Article  PubMed  Google Scholar 

  24. Tilg H, Diehl AM. Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med. 2000;343:1467–76.

    Article  CAS  PubMed  Google Scholar 

  25. Duseja A, Murlidharan R, Bhansali A, et al. Assessment of insulin resistance and effect of metformin in nonalcoholic steatohepatitis—a preliminary report. Indian J Gastroenterol. 2004;23:12–5.

    PubMed  Google Scholar 

  26. Duseja A, Das A, Das R, et al. Clinicopathological profile of Indian patients with nonalcoholic fatty liver disease is different from that in the west. Dig Dis Sci. 2007;52:2368–74.

    Article  PubMed  Google Scholar 

  27. Duseja A, Das A, Dhiman RK, et al. Indian patients with nonalcoholic fatty liver disease presenting with raised transaminases are different at presentation. World J Gastroenterol. 2007;13:649–50.

    PubMed  Google Scholar 

  28. Madan K, Batra Y, Gupta SD, et al. Non-alcoholic fatty liver disease may not be a severe disease at presentation among Asian Indians. World J Gastroenterol. 2006;12:3400–5.

    PubMed  Google Scholar 

  29. Amarapurkar DN, Patel ND. Prevalence of metabolic syndrome in non-diabetic and non-cirrhotic patients with non-alcoholic steatohepatitis. Trop Gastroenterol. 2004;25:125–9.

    PubMed  Google Scholar 

  30. Sreenivasa Baba C, Alexander G, Kalyani B, et al. Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis. J Gastroenterol Hepatol. 2006;21(1 Pt 1):191–8.

    Article  PubMed  Google Scholar 

  31. Duseja A, Thumburu KK, Das A, et al. Insulin tolerance test is comparable to homeostasis model assessment for insulin resistance in patients with nonalcoholic fatty liver disease. Indian J Gastroenterol. 2007;26:170–3.

    PubMed  Google Scholar 

  32. Bajaj S, Nigam P, Luthra A, et al. A case-control study on insulin resistance, metabolic co-variates and prediction score in non-alcoholic fatty liver disease. Indian J Med Res. 2009;129:285–92.

    CAS  PubMed  Google Scholar 

  33. Willett WC, Dietz WH, Colditz GA. Guidelines for healthy weight. N Engl J Med. 1999;341:427–34.

    Article  CAS  PubMed  Google Scholar 

  34. Amarapurkar DN, Amarapurkar AD. Nonalcoholic steatohepatitis: clinicopathological profile. J Assoc Physicians India. 2000;48:311–3.

    CAS  PubMed  Google Scholar 

  35. Agarwal SR, Malhotra V, Sakhuja P, Sarin SK. Clinical, biochemical and histological profile of nonalcoholic steatohepatitis. Indian J Gastroenterol. 2001;20:183–6.

    CAS  PubMed  Google Scholar 

  36. Steering Committee of the Western Pacific region of the World Health Organization. The International Association for the study of Obesity and the International Study Task Force. The Asia-Pacific perspective; redefining obesity and its treatment. Health Communications, Australia. 2000; 8–56.

  37. Dudeja V, Misra A, Pandey RM, Devina G, Kumar G, Vikram NK. BMI does not accurately predict overweight in Asian Indians in northern India. Br J Nutr. 2001;86:105–12.

    Article  CAS  PubMed  Google Scholar 

  38. Deurenberg-Yap M, Chew SK, Deurenberg P. Elevated body fat percentage and cardiovascular risks at low body mass index levels among Singaporean Chinese, Malays and Indians. Obes Rev. 2002;3:209–15.

    Article  CAS  PubMed  Google Scholar 

  39. Misra A, Misra R. Asian Indians and insulin resistance syndrome: global perspective. Metab Syndr Relat Disord. 2003;1:277–83.

    Article  PubMed  Google Scholar 

  40. Ko GT, Chan JC, Cockram CS, Woo J. Prediction of hypertension, diabetes, dyslipidaemia or albuminuria using simple anthropometric indexes in Hong Kong Chinese. Int J Obes Relat Metab Disord. 1999;23:1136–42.

    Article  CAS  PubMed  Google Scholar 

  41. Dhiman RK, Duseja A, Chawla Y. Asians need different criteria for defining obesity. Arch Intern Med. 2005;165:1069–70.

    Article  PubMed  Google Scholar 

  42. Misra A, Chowbey P, Makkar BM, et al. Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J Assoc Physicians India. 2009;57:163–70.

    CAS  PubMed  Google Scholar 

  43. Misra A, Vikram NK. Clinical and pathophysiological consequences of abdominal adiposity and abdominal adipose tissue depots. Nutrition. 2003;19:457–66.

    Article  PubMed  Google Scholar 

  44. Madan K, Bhardwaj P, Thareja S, Gupta SD, Saraya A. Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD). J Clin Gastroenterol. 2006;40:930–5.

    Article  CAS  PubMed  Google Scholar 

  45. Bhardwaj P, Madan K, Thareja S, Joshi YK, Saraya A. Comparative redox status in alcoholic liver disease and nonalcoholic fatty liver disease. Hepatol Int. 2008;2:202–8.

    Article  PubMed  Google Scholar 

  46. Narasimhan S, Gokulakrishnan K, Sampathkumar R, et al. Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetes. Clin Biochem. 2010;43:815–21.

    Article  CAS  PubMed  Google Scholar 

  47. Das KS, Balakrishnan V, Mukherjee S, Vasudevan DM. Evaluation of blood oxidative stress-related parameters in alcoholic liver disease and non-alcoholic fatty liver disease. Scand J Clin Lab Invest. 2008;68:323–34.

    Article  CAS  PubMed  Google Scholar 

  48. Duseja A, Das R, Das A, Dhiman RK, Chawla Y, Garewal G. Serum iron and hepatic iron overload in patients with nonalcoholic steatohepatitis. Dig Dis Sci. 2006;51:1730–1.

    Article  PubMed  Google Scholar 

  49. Duseja A, Das R, Nanda M, Das A, Garewal G, Chawla Y. Nonalcoholic steatohepatitis in Asian Indians is neither associated with iron overload nor with HFE gene mutations. World J Gastroenterol. 2005;21:393–5.

    Google Scholar 

  50. Sharma R, Sinha S, Danishad KA, et al. Investigation of hepatic gluconeogenesis pathway in non-diabetic Asian Indians with non-alcoholic fatty liver disease using in vivo ((31)P) phosphorus magnetic resonance spectroscopy. Atherosclerosis. 2009;203:291–7.

    Article  CAS  PubMed  Google Scholar 

  51. Nagarajan P, Venkatesan R, Kumar M, Usmani A, Majumdar SS. Macaca radiata (bonnet monkey): a spontaneous model of nonalcoholic fatty liver disease. Liver Int. 2008;28:856–64.

    Article  CAS  PubMed  Google Scholar 

  52. Duseja A, Das A, Das R, Dhiman RK, Chawla Y, Bhansali A. Unconjugated hyperbilirubinemia in nonalcoholic steatohepatitis—is it Gilbert’s syndrome? Trop Gastroenterol. 2005;26:123–5.

    PubMed  Google Scholar 

  53. Kalra N, Duseja A, Das A, et al. Chemical shift magnetic resonance imaging is helpful in detecting hepatic steatosis but not fibrosisin patients with nonalcoholic fatty liver disease (NAFLD). Ann Hepatol. 2009;8:21–5.

    PubMed  Google Scholar 

  54. Vasdev N, Kakati AG, Saigal S, Nayak NC. Spectrum of histological features in non-alcoholic fatty liver disease. Natl Med J India. 2007;20:282–7.

    PubMed  Google Scholar 

  55. Singh DK, Sakhuja P, Malhotra V, Gondal R, Sarin SK. Independent predictors of steatohepatitis and fibrosis in Asian Indian patients with non-alcoholic steatohepatitis. Dig Dis Sci. 2008;53:1967–76.

    Article  PubMed  Google Scholar 

  56. Musso G, Gambino R, Cassader M, Pagano G. A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease. Hepatology. 2010;52:79–104.

    Article  CAS  PubMed  Google Scholar 

  57. Duseja A, Das A, Dhiman RK, et al. Metformin is effective in achieving biochemical response in patients with nonalcoholic fatty liver disease (NAFLD) not responding to lifestyle interventions. Ann Hepatol. 2007;6:222–6.

    CAS  PubMed  Google Scholar 

  58. Madan K, Batra Y, Gupta DS, et al. Vitamin E-based therapy is effective in ameliorating transaminasemia in nonalcoholic fatty liver disease. Indian J Gastroenterol. 2005;24:251–5.

    PubMed  Google Scholar 

  59. Satapathy SK, Garg S, Chauhan R, et al. Beneficial affects of tumor necrosis factor-alfa inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis. Am J Gastroenterol. 2004;99:1946–52.

    Article  CAS  PubMed  Google Scholar 

  60. Satapathy SK, Sakhuja P, Malhotra V, Sharma BC, Sarin SK. Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis. J Gastroenterol Hepatol. 2007;22:634–8.

    CAS  PubMed  Google Scholar 

  61. Sanal MG. Adipose tissue transplantation may be a potential treatment for diabetes, atherosclerosis and nonalcoholic steatohepatitis. Med Hypotheses. 2009;72:247–9.

    Article  CAS  PubMed  Google Scholar 

  62. Petersen KF, Dufour S, Feng J, et al. Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men. Proc Natl Acad Sci USA. 2006;103:18273–7.

    Article  CAS  PubMed  Google Scholar 

  63. Duseja A. Nonalcoholic fatty liver disease in India—is it different? Trop Gastroenterol. 2006;27:142–6.

    PubMed  Google Scholar 

  64. Amarapurkar DN, Hashimoto E, Lesmana LA, Sollano JD, Chen PJ. Asia-Pacific Working Party on NAFLD. How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? J Gastroenterol Hepatol. 2007;22:788–93.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160 012, India

    Ajay Duseja

Authors
  1. Ajay Duseja
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ajay Duseja.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Duseja, A. Nonalcoholic fatty liver disease in India – a lot done, yet more required!. Indian J Gastroenterol 29, 217–225 (2010). https://doi.org/10.1007/s12664-010-0069-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12664-010-0069-1

Keywords

Search

Navigation